Outlook: Bearish
Indoco Remedies Ltd. is a fully integrated, research-oriented pharma company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). This company have seven decades of presence in the Indian Pharma market and a strong foothold in the international market across 55 countries. Indoco, a US$ 200 million company, employs around 6000 personnel, including over 400 skilled scientists.
xCalData identifies Indoco will continue its bearish phase in the next 4 days (Jul5) and trend in the range of 339 and 318.
Majority of the technical ratios trend towards bearish side of the spectrum. Some of the trend indicators like RSI clearly indicate bearish view while some indicators like MFI indicate Bullish view.
Collectively, xCalData suggests the stock would be in bearish zone for till Jul5.
xCalData offers unbiased insights into stocks.
For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData
Disclaimer: The securities quoted are for illustration only and are not recommendatory